Global Fertility Services Market Share Grows Steadily at a CAGR of 6.45%

Introduction

The global fertility services market size was estimated at USD 45.33 billion in 2025 and is anticipated to grow till USD 79.28 billion by 2034, growing at a CAGR of 6.45% from 2026-2034.

The market growth is primarily attributed to rising global infertility prevalence, coupled with delayed parenthood and declining fertility rates across developed and emerging economies. Additionally, advancements in assisted reproductive technologies (ART) such as IVF, ICSI, and cryopreservation also boost the market growth.

Market Dynamics

Advancements in Assisted Reproductive Technologies (ART)

The advancements in assisted reproductive technologies have significantly increased their adoption across fertility treatments due to higher success rates and improved patient outcomes. As ICSI has become the standard of care for male infertility, accounting for over 70% of IVF cycles in Europe. Therefore, advancements in ART boost the demand for fertility services.

Growing Demand for Fertility Preservation

The rising demand for fertility preservation is creating significant opportunities for market growth.

• For instance, according to the Human Fertilisation and Embryology Authority 2024, egg freezing cycles increased from fewer than 2,500 in 2019 to nearly 5,800 cycles in 2023, reflecting rapid uptake among women delaying childbearing.

Therefore, the expanding adoption of fertility preservation services is a key opportunity for market growth.

Regional Analysis

North America is the most significant global fertility services market shareholder. The growth is attributed to a robust healthcare infrastructure that facilitates access to advanced fertility treatments. The significant demand for these services is largely driven by shifting societal trends, including delayed family planning and increased awareness of available fertility options. Moreover, government initiatives and insurance coverage for treatments such as in vitro fertilization (IVF) have further enhanced accessibility for individuals and couples seeking assistance.

The Asia Pacific region is experiencing a rapid growth rate in the market. Key players such as India, China, and Japan are at the forefront of this expansion, witnessing an increase in the number of fertility clinics and greater access to advanced treatments like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Favorable government policies, including relaxed regulations on fertility treatments and subsidies to support patients, are further driving the rapid growth of this market.

Key Highlights

• By procedure, the market is segmented into in vitro fertilization with intracytoplasmic sperm injection (IVF with ICSI), intrauterine insemination (IUI), in vitro fertilization without intracytoplasmic sperm injection (IVF without ICSI), surrogacy, and others. The In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI) segment is expected to register the fastest CAGR of 6.19% from 2026 to 2034. This growth is attributed to the high success rate of this procedure over conventional IVF.
• By Service, the market is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. The Egg & Embryo Banking segment is estimated to grow at the fastest pace with a CAGR of 71%, owing to the rising trend of delayed parenthood, which is increasing demand for elective egg freezing.
• On the basis of service provider, the market is divided into fertility clinics, hospitals, surgical centers, and clinical research institutes. The fertility clinics segment dominated the market in 2025 and is estimated to grow at the fastest CAGR during the forecast period. This growth is attributed to specialized infrastructure and expertise offered by dedicated fertility centers and the expansion of these clinics.
• Asia Pacific is estimated to be the fastest-growing region in the global market, with a CAGR of 7.25%. This growth is attributed to a rapid decline in fertility rates across countries such as China, Japan, and South Korea, and the implementation of supportive policies.

Competitive Players

IVI-RMA Global (IVIRMA), Virtus Health, Monash IVF Group, Genea Group, CARE Fertility Group, Eugin Group, Dallas IVF, Boston IVF, Jinxin Fertility, Apollo Hospitals, Medicover Group, Apricity Fertility UK Limited, King’s Fertility Limited, Mayo Foundation for Medical Education and Research

Recent Developments

• 2nd June 2025: FIGO launches oncofertility best practices for preserving fertility for cancer patients.

Segmentation

1. By Procedure
   1. In Vitro Fertilization with Intracytoplasmic Sperm Injection (IVF with ICSI)
   2. Intrauterine Insemination (IUI)
   3. In Vitro Fertilization without Intracytoplasmic Sperm Injection (IVF without ICSI)
   4. Surrogacy
   5. Others
2. By Service
   1. Fresh Non-donor
   2. Frozen Non-donor
   3. Egg & Embryo Banking
   4. Fresh Donor
   5. Frozen Donor
3. By Service Provider
   1. Fertility Clinics
   2. Hospitals
   3. Surgical Centers
   4. Clinical Research Institutes
4. By Type
   1. Male Fertility Services
   2. Female Fertility Services
5. By Region
   1. North America
   2. Europe
   3. Asia-Pacific
   4. Latin America
   5. The Middle East and Africa